Q4 2024 Holdings
Filed 2025-02-14 | 61 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $245.4M | 1,550,280 | 17.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $118.2M | 2,793,987 | 8.6% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $71.5M | 774,227 | 5.2% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $63.9M | 359,393 | 4.7% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $62.1M | 504,193 | 4.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $52.1M | 428,771 | 3.8% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $45.2M | 1,696,752 | 3.3% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $42.7M | 651,344 | 3.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $41.8M | 116,005 | 3.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $41.6M | 491,726 | 3.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $38.1M | 3,149,522 | 2.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $36.2M | 524,267 | 2.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $35.4M | 1,995,594 | 2.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.0M | 757,248 | 2.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $31.0M | 346,571 | 2.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $27.5M | 1,069,090 | 2.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.9M | 110,157 | 1.9% |
| Alkermes Plc(ALKS) | SHS | G01767105 | $25.7M | 894,266 | 1.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $25.2M | 1,071,498 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $22.6M | 290,210 | 1.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $22.2M | 397,428 | 1.6% |
| Globus Med Inc(GMED) | CL A | 379577208 | $20.2M | 244,700 | 1.5% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $19.8M | 37,896 | 1.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $17.7M | 256,281 | 1.3% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $17.2M | 2,194,278 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $16.8M | 5,471,299 | 1.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $13.6M | 253,262 | 1.0% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $13.3M | 2,304,901 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $11.9M | 4,280,308 | 0.9% |
| Eli Lilly & Co(LLY) | COM | 532457108 | $11.1M | 14,364 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.8M | 402,773 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.7M | 560,723 | 0.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $10.0M | 3,758,686 | 0.7% |
| Inari Med Inc(NARIUSD) | COM | 45332Y109 | $9.2M | 180,456 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.7M | 658,627 | 0.6% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $8.5M | 100,000 | 0.6% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $8.1M | 527,190 | 0.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $7.9M | 746,824 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.4M | 823,160 | 0.5% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $4.6M | 1,306,482 | 0.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.5M | 1,795,880 | 0.3% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $4.4M | 95,305 | 0.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $4.2M | 200,000 | 0.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $3.0M | 40,000 | 0.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.9M | 52,042 | 0.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $2.4M | 343,206 | 0.2% |
| Danaher Corporation(DHR) | COM | 235851102 | $2.3M | 10,000 | 0.2% |
| Nextcure Inc | COM | 65343E108 | $2.1M | 2,671,856 | 0.2% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $1.8M | 132,927 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.5M | 95,375 | 0.1% |